I realize this answer is very late ... but this is the contraindication of taking Ronec DM with cardiovascular conditions.
Sympathomimetics (Includes Rondec-DM) ↔ Cardiovascular Disease
Severe Potential Hazard, High plausibility
Applies to: Cardiovascular Disease, Cerebrovascular Insufficiency, Hyperthyroidism, Pheochromocytoma
Sympathomimetic agents may cause adverse cardiovascular effects, particularly when used in high dosages and/or in susceptible patients. In cardiac tissues, these agents may produce positive chronotropic and inotropic effects via stimulation of beta-1 adrenergic receptors. Cardiac output, oxygen consumption, and the work of the heart may be increased. In the peripheral vasculature, vasoconstriction may occur via stimulation of alpha-1 adrenergic receptors. Palpitations, tachycardia, arrhythmia, hypertension, reflex bradycardia, coronary occlusion, cerebral vasculitis, myocardial infarction, cardiac arrest, and death have been reported. Some of these agents, particularly ephedra alkaloids (ephedrine, ma huang, phenylpropanolamine), may also predispose patients to hemorrhagic and ischemic stroke. Therapy with sympathomimetic agents should generally be avoided or administered cautiously in patients with sensitivity to sympathomimetic amines, hyperthyroidism, or underlying cardiovascular or cerebrovascular disorders. These agents should not be used in patients with severe coronary artery disease or severe/uncontrolled hypertension.
Search for questions
Still looking for answers? Try searching for what you seek or ask your own question.
Posted 19 Jan 2010 • 3 answers
Posted 8 Nov 2011 • 2 answers
Posted 8 Feb 2012 • 4 answers
Posted 7 Mar 2013 • 3 answers
Posted 16 Aug 2015 • 1 answer